Research Topics
Species | J P GalanaudSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancyJ P Galanaud
Vascular Medicine Unit, University Hospital, Montpellier, France
J Thromb Haemost 8:707-13. 2010..Half of all venous thromboembolism (VTE) cases during pregnancy are associated with a maternal thrombophilia. The influence of paternal genotype on the placenta and in the genesis of VTE has not been described...- The post-thrombotic syndrome: a 2012 therapeutic updateJean Philippe Galanaud
Department of Internal Medicine, Montpellier University Hospital and EA 2992, Montpellier 1 University, Montpellier, France
Curr Treat Options Cardiovasc Med 15:153-63. 2013..These techniques are still under evaluation and the level of evidence supporting their use is low... - [Epidemiology and management of isolated distal deep venous thrombosis]J P Galanaud
Unité de médecine vasculaire, Departement de Medecine Interne, CHU de Montpellier, 80, avenue Gaston Fliche, 34295 Montpellier Cedex 5, France
Rev Med Interne 33:678-85. 2012..Ongoing therapeutic trials should provide important data necessary to establish an evidence-based mode of care, especially about the need to treat distal DVT at low risk of extension with anticoagulants... - Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studiesJ P Galanaud
Department of Internal Medicine, Montpellier University Hospital, and Research unit EA 2992, University Montpellier 1, Montpellier, France
J Thromb Haemost 10:1004-11. 2012.... - Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV studyJean Philippe Galanaud
Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, Centre Hospitalier Universitaire de Montpellier, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
Thromb Haemost 105:31-9. 2011..Larger studies are needed to evaluate predictive factors for adverse outcome... - Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV studyJean Philippe Galanaud
Centre Hospitalier Universitaire, Vascular Medicine Unit, 34295 Montpellier cedex 05, France
Thromb Haemost 102:493-500. 2009..Symptomatic isolated distal DVT differs from symptomatic proximal DVT both in terms of risk factors and clinical outcome. Whether these differences should influence the clinical management of these two events remains to be determined... - Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patientsJ P Galanaud
Vascular Medicine Unit, University Hospital, Montpellier, France
J Thromb Haemost 7:2028-34. 2009..The clinical significance of symptomatic isolated distal deep vein thrombosis (DVT) is uncertain. Consequently, this leads to important disparities in its management... - Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosisJean Philippe Galanaud
Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
J Vasc Surg 52:932-8, 938.e1-2. 2010..Despite their high prevalence, MCVT and DCVT have never been compared so far, which prevents possible modulation of distal DVT management according to the kind of distal DVT (MCVT or DCVT)... - Risk factors and early outcomes of patients with symptomatic distal vs. proximal deep-vein thrombosisJean Philippe Galanaud
Vascular Medicine Unit, Department of Internal Medicine, Montpellier University Hospital, Grenoble, France
Curr Opin Pulm Med 17:387-91. 2011..Therefore, iDDVT management varies widely from one country/physician to another... 
[Calf vein thrombosis: to treat or not to treat? Epidemiology, management and problematics]J P Galanaud
Service de Médecine Interne et Maladies Vasculaires, Hopital Saint Eloi, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
J Mal Vasc 32:225-8. 2007..CACTUS (compression stocking + placebo versus compression stocking + heparin, for six weeks) that will start in September 2007, should provide answers the following question: should calf vein thrombosis be treated with anticoagulants?..- [Distal deep-venous thrombosis: diagnostic and therapeutic issues]I Quere
Service de Médecine Interne et Maladies Vasculaires, centre hospitalier de Montpellier, 80, avenue Gaston Fliche, 34295 Montpellier Cedex 5, France
Rev Med Interne 29:491-7. 2008..FUTURE PROSPECTS AND PROJECTS: Prospective comparative clinical trials are necessary in distal-venous thrombosis and ongoing Cactus study addresses this therapeutic dilemma... - [Prevalence and risk factors of peripheral arterial disease in an outpatient screening campaign]T Behar
EA 2992, Service de Medecine Vasculaire, Departement de Medecine Interne, CHU de Montpellier, Universite Montpellier 1, 80, avenue Augustin Fliche, 34295 Montpellier Cedex 5, France
J Mal Vasc 38:22-8. 2013..Peripheral arterial disease (PAD) is an important predictor of cardiovascular disease with major medico-economic consequences. However, systematic screening of asymptomatic patients free from history of cardiovascular disease is debated... - The history and historical treatments of deep vein thrombosisJ P Galanaud
Department of Internal Medicine, Montpellier University Hospital, Montpellier, France
J Thromb Haemost 11:402-11. 2013..In these times of change regarding DVT treatment, mainly marked by the arrival of new oral anticoagulants, efforts of physicians through the ages to treat this common disease provide a beautiful example of the history of knowledge...